To access this element change to forms mode OFF
Grant Award View - GA217927
Psilocybin-assisted therapy for refractory Functional Neurological...
GA ID:
GA217927
Agency:
Department of Health and Aged Care
Approval Date:
4-Nov-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$1,448,343.80
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Psilocybin-assisted therapy for refractory Functional Neurological Disorder
Purpose:
Functional Neurological Disorder (FND) is a mental disorder that presents with neurological symptoms, such as paralysis, which are of psychological origin. Many patients do not respond to standard therapy, and potentially face lifelong disability as a result. We believe that adding psilocybin to standard therapy will allow them to recover completely. We will test this using a randomised controlled trial of psilocybin plus standard therapy compared to placebo plus standard therapy.
GO ID:
GO Title:
MRFF - Clinical Trials Activity Initiative - 2021 Innovative Therapies for Mental Illness - Grant Opportunity
Internal Reference ID:
2021/MRF2012410
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA